Old Articles: <Older 8581-8590 Newer> |
|
Chemistry World May 7, 2013 Phillip Broadwith |
Buy Viagra online - direct from the manufacturer Pharmaceutical giant Pfizer is cutting out the pharmacist middle-man by setting up a website for Viagra (sildenafil citrate) sales. |
Chemistry World May 3, 2013 Phillip Broadwith |
Judge reverses jury decision over $6.5m Takeda payout A judge has thrown out the jury's verdict in a case between Japanese drugmaker Takeda and a US man who claims that the company's drug caused his bladder cancer. |
Chemistry World April 29, 2013 |
Bayer buys Conceptus for $1.1bn The deal gives Bayer access to Essure, a non-surgical procedure for permanent birth control. |
Chemistry World April 25, 2013 Phillip Broadwith |
Portable detector shines light on fake drugs The CD-3 counterfeit detection device uses a variety of different wavelengths of light to visually compare tablets, capsules and their packaging with genuine reference samples. |
Chemistry World April 24, 2013 Phillip Broadwith |
US sues Novartis over alleged kickbacks Novartis has used illegal payments to induce pharmacies to switch kidney transplant patients onto its immunosuppressant drug Myfortic (mycophenolate sodium), a US government lawsuit alleges. |
Chemistry World April 23, 2013 Phillip Broadwith |
Ireland picks preferred drugs Ireland has become the first country to identify lists of 'preferred drugs'. Ensuring patients use the best value-for-money drugs could save patients and taxpayers millions of euros, says the Irish Health Service Executive. |
Chemistry World April 19, 2013 Phillip Broadwith |
Objections raised to GSK pay-for-delay deals The UK Office of Fair Trading has said that GlaxoSmithKline's deals to delay generic drugs infringed competition laws. |
Chemistry World April 19, 2013 Sarah Houlton |
Thermo Fisher to buy Life Technologies in $15.8bn deal Life Technologies specializes in research products, with a particular focus on genetic sequencing and DNA analysis. |
Chemistry World April 17, 2013 Mark Peplow |
Sanofi launches malaria drug production On 11 April, the Paris-based pharmaceutical company Sanofi officially launched a new production facility in Garessio, Italy, to make artemisinin -- the precursor to artemisinin-based combination therapies, the most effective drugs against the deadliest malaria parasite. |
Chemistry World April 9, 2013 Phillip Broadwith |
Morning sickness drug reintroduced to US Diclegis (doxylamine succinate and pyridoxine hydrochloride), contains the same active ingredients as Benedictin, which was produced by Merrel Dow and withdrawn from the market in 1983 after a string of lawsuits claiming it caused birth defects. |
<Older 8581-8590 Newer> Return to current articles. |